Continue to site >
Trending ETFs

Name

As of 11/20/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$11.65

$518 M

0.00%

1.74%

Vitals

YTD Return

-2.8%

1 yr return

2.3%

3 Yr Avg Return

-8.6%

5 Yr Avg Return

-3.9%

Net Assets

$518 M

Holdings in Top 10

41.5%

52 WEEK LOW AND HIGH

$11.6
N/A
N/A

Expenses

OPERATING FEES

Expense Ratio 1.74%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover 69.37%

Redemption Fee N/A


Min Investment

Standard (Taxable)

N/A

IRA

N/A


Fund Classification

Fund Type

Closed-end mutual fund


Name

As of 11/20/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$11.65

$518 M

0.00%

1.74%

XTHWX - Profile

Distributions

  • YTD Total Return -2.8%
  • 3 Yr Annualized Total Return -8.6%
  • 5 Yr Annualized Total Return -3.9%
  • Capital Gain Distribution Frequency N/A
  • Net Income Ratio 0.53%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Monthly

Fund Details

  • Legal Name
    Tekla World Healthcare Fund
  • Fund Family Name
    Tekla Capital Management LLC
  • Inception Date
    Jul 01, 2015
  • Shares Outstanding
    37401893
  • Share Class
    Other
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Daniel Omstead

Fund Description


XTHWX - Performance

Return Ranking - Trailing

Period XTHWX Return Category Return Low Category Return High Rank in Category (%)
YTD -2.8% -27.4% 19.9% 93.08%
1 Yr 2.3% -13.7% 48.1% 97.48%
3 Yr -8.6%* -28.0% 9.5% 92.76%
5 Yr -3.9%* -7.8% 12.2% 97.95%
10 Yr N/A* 0.2% 13.1% N/A

* Annualized

Return Ranking - Calendar

Period XTHWX Return Category Return Low Category Return High Rank in Category (%)
2023 -8.6% -12.6% 19.0% 97.48%
2022 -16.7% -53.9% 3.2% 77.63%
2021 6.7% -39.6% 24.2% 24.34%
2020 -0.7% -13.6% 178.2% 95.97%
2019 13.8% 3.8% 63.8% 89.47%

Total Return Ranking - Trailing

Period XTHWX Return Category Return Low Category Return High Rank in Category (%)
YTD -2.8% -27.4% 19.9% 93.08%
1 Yr 2.3% -13.7% 48.1% 97.48%
3 Yr -8.6%* -28.0% 9.5% 92.76%
5 Yr -3.9%* -7.8% 12.2% 97.95%
10 Yr N/A* 0.2% 13.1% N/A

* Annualized

Total Return Ranking - Calendar

Period XTHWX Return Category Return Low Category Return High Rank in Category (%)
2023 -8.6% -12.6% 19.0% 97.48%
2022 -16.7% -53.9% 3.7% 81.58%
2021 6.7% -33.9% 26.0% 61.18%
2020 -0.7% -0.7% 180.6% 100.00%
2019 19.7% 4.6% 63.8% 87.97%

NAV & Total Return History


XTHWX - Holdings

Concentration Analysis

XTHWX Category Low Category High XTHWX % Rank
Net Assets 518 M 6.66 M 45.7 B 56.60%
Number of Holdings 213 25 430 5.03%
Net Assets in Top 10 229 M 2.12 M 22.1 B 58.49%
Weighting of Top 10 41.47% 18.4% 79.7% 77.99%

Top 10 Holdings

  1. UnitedHealth Group Inc 7.71%
  2. Roche Holding AG ADR 5.40%
  3. AstraZeneca PLC ADR 4.61%
  4. Thermo Fisher Scientific Inc 4.12%
  5. Pfizer Inc 3.91%
  6. Johnson & Johnson 3.82%
  7. Abbott Laboratories 3.64%
  8. AbbVie Inc 3.54%
  9. Medtronic PLC 3.36%
  10. Anthem Inc 3.29%

Asset Allocation

Weighting Return Low Return High XTHWX % Rank
Stocks
105.50% 87.34% 106.13% 1.26%
Bonds
11.89% 0.00% 12.39% 1.26%
Cash
2.97% 0.00% 33.01% 39.62%
Preferred Stocks
1.79% 0.00% 7.86% 15.72%
Convertible Bonds
0.00% 0.00% 0.37% 68.83%
Other
-22.15% -22.99% 23.24% 99.37%

Stock Sector Breakdown

Weighting Return Low Return High XTHWX % Rank
Healthcare
94.76% 59.26% 100.00% 97.40%
Real Estate
5.24% 0.00% 5.89% 1.30%
Utilities
0.00% 0.00% 0.00% 66.88%
Technology
0.00% 0.00% 22.69% 70.78%
Industrials
0.00% 0.00% 7.02% 70.13%
Financial Services
0.00% 0.00% 1.60% 78.57%
Energy
0.00% 0.00% 0.00% 66.88%
Communication Services
0.00% 0.00% 9.11% 69.48%
Consumer Defense
0.00% 0.00% 25.73% 69.48%
Consumer Cyclical
0.00% 0.00% 1.92% 68.83%
Basic Materials
0.00% 0.00% 7.16% 75.97%

Stock Geographic Breakdown

Weighting Return Low Return High XTHWX % Rank
US
77.78% 66.06% 104.41% 84.91%
Non US
27.72% 0.00% 28.87% 3.77%

Bond Sector Breakdown

Weighting Return Low Return High XTHWX % Rank
Corporate
81.57% 0.00% 81.57% 0.72%
Cash & Equivalents
18.43% 0.00% 100.00% 6.29%
Derivative
0.00% 0.00% 23.24% 78.62%
Securitized
0.00% 0.00% 0.00% 67.39%
Municipal
0.00% 0.00% 0.00% 67.39%
Government
0.00% 0.00% 29.44% 67.39%

Bond Geographic Breakdown

Weighting Return Low Return High XTHWX % Rank
US
8.56% 0.00% 11.75% 1.26%
Non US
3.33% 0.00% 3.33% 0.63%

XTHWX - Expenses

Operational Fees

XTHWX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 1.74% 0.08% 4.48% 23.27%
Management Fee 1.00% 0.03% 1.25% 93.08%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.03% 0.25% N/A

Sales Fees

XTHWX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 3.50% 5.75% N/A
Deferred Load N/A 1.00% 1.00% N/A

Trading Fees

XTHWX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 1.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

XTHWX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 69.37% 0.00% 238.00% 82.96%

XTHWX - Distributions

Dividend Yield Analysis

XTHWX Category Low Category High XTHWX % Rank
Dividend Yield 0.00% 0.00% 6.24% 79.87%

Dividend Distribution Analysis

XTHWX Category Low Category High Category Mod
Dividend Distribution Frequency Monthly Annual Monthly Annual

Net Income Ratio Analysis

XTHWX Category Low Category High XTHWX % Rank
Net Income Ratio 0.53% -2.54% 1.85% 14.47%

Capital Gain Distribution Analysis

XTHWX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually

Distributions History

View More +

XTHWX - Fund Manager Analysis

Managers

Daniel Omstead


Start Date

Tenure

Tenure Rank

Jun 26, 2015

6.93

6.9%

Omstead is president and chief executive officer of Tekla Capital Management, formerly known as Hambrecht & Quist Capital Management, Inc. Before joining the adviser, Omstead was president and CEO of Reprogenesis, Inc., a private development stage biotech company developing therapies in the field of regenerative medicine. Before joining Reprogenesis, he was senior vice president, research and development at Cytotherapeutics, Inc., a public biotech company that developed CNS therapies.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.02 24.72 7.88 0.25